Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock
VS

Stock highlights

Stock comparison highlights
Stock name
Johnson & JohnsonRoche Holding
Last price
$255.54CHF 377.80
Currency
USD
CHF
$610BCHF 303B
38.4724.70
$6.58CHF 15.33
0.210.34
$5.28CHF 9.80
2.12%2.59%
Sector
HealthHealth
Employees
138,200103,249
Ticker
$JNJFr. ROP
Primary listing
NYSEXSWX

Performance

CumulativeRolling yearsLump sum investment

Invest in $JNJ or Fr.ROP on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.